mRNA as a versatile tool for exogenous protein expression
AN Kuhn, T Beissert, P Simon, B Vallazza… - Current gene …, 2012 - ingentaconnect.com
… But mainly due to the risks associated with permanent genetic alteration of cells, safety and
… In the last years, synthetic messenger RNA has emerged as powerful tool to deliver genetic …
… In the last years, synthetic messenger RNA has emerged as powerful tool to deliver genetic …
… of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses
O Stanek, I Linhartova, L Majlessi, C Leclerc… - Molecular …, 2012 - Springer
… in development of vaccines inducing specific T-cell responses. … , such as those derived from
the TAT protein, or of various … The 5′ and 3′ ends of the ORF were modified by insertion of …
the TAT protein, or of various … The 5′ and 3′ ends of the ORF were modified by insertion of …
Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system
SS Han, J Lee, Y Jung, MH Kang, JH Hong, MS Cha… - Vaccine, 2015 - Elsevier
… Tat protein, which is essential for HIV-1 replication, has a … As expected, vRPS-CTP/p24
induced strong CTL responses in … B7.2 to the immune response to recombinant modified vaccinia …
induced strong CTL responses in … B7.2 to the immune response to recombinant modified vaccinia …
[PDF][PDF] Ovarian cancer treatment with a liposome formulated mRNA vaccine in combination with (neo-) adjuvant chemotherapy: Study protocol of the OLIVIA phase I …
ST Paijens, AKL Reyners, M de Bruyn… - Tumor immunology and … - research.rug.nl
… the induction of a vaccine specific systemic immune response, … Modification of CEA with
both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC …
both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC …
[HTML][HTML] Cell type preference of a novel human derived cell-permeable peptide dNP2 and TAT in murine splenic immune cells
… is appropriate target for DC vaccination using cell-penetrating … potent target cell type for
modulating the immune system … could modulated OVA-induced allergic T cell responses in vivo …
modulating the immune system … could modulated OVA-induced allergic T cell responses in vivo …
Antigen-specific mRNA transfection of autologous dendritic cells
F Benencia - Cancer Vaccines: Methods and Protocols, 2014 - Springer
… inducing a robust CD8 (cytotoxic) T cell immune response. In … been assayed in order to
activate these RNA-pulsed cells [21]. … around 2–4 × 10 8 DC in our hands when using two mice. …
activate these RNA-pulsed cells [21]. … around 2–4 × 10 8 DC in our hands when using two mice. …
Jeong-Im Sin
SY Lee - bioseek.eu
… , we selected 2 tumor cells, MC32-S2-2 and MC32-S4-2, which have the ability to form tumors
in CEA DNA vaccine-… Antitumor activity and immune responses induced by a recombinant …
in CEA DNA vaccine-… Antitumor activity and immune responses induced by a recombinant …
[HTML][HTML] The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis
… effect of Tat-Hsp-27 in preventing hypoxia-induced cellular … impact of Tat-Hsp27 mediated
blockade on both apoptotic … Our result confirms other studies that PTD is able to deliver …
blockade on both apoptotic … Our result confirms other studies that PTD is able to deliver …
Bibliography Current World Literature Vol 21 No 6 November 2009
E Arriola, C Marchio, D Tan - Proc Natl Acad Sci USA, 2008 - journals.lww.com
Bundred NJ, Campbell ID, Davidson N, et al. Effective inhibition of aromatase inhibitor-associated
bone loss by zoledronic acid in postmenopausal women with early breast cancer …
bone loss by zoledronic acid in postmenopausal women with early breast cancer …
Efeito protetor in vivo de vacinas de células dendríticas sensibilizadas com RNA de células MC-38 pré-tratadas com agentes antineoplásticos em concentrações …
MR Camargo - 2014 - repositorio.unesp.br
… enhance the efficacy of anti-tumor vaccinations by neutralizing … is to in vivo stimulate the
adaptive immune system to achieve tumor … for inducing a specific T response against CEA [106]. …
adaptive immune system to achieve tumor … for inducing a specific T response against CEA [106]. …